DATE [JIAYUAN.COM INTERNATIONAL] F-1/A: AMENDMENT NO. 4 TO FormF-1 REGISTRATION STATEMENT Jiayuan.com

[AMENDMENT NO. 4 TO FormF-1 REGISTRATION STATEMENT Jiayuan.com International Not Applicableyman Islands 7371 Not Applicable Room1005, Changxin Building CTrporation System (Name,dress,luding zipde, and telephone number,luding areade, ofent for service)pies to:vid S. Wang, Esq.vid T. Zhang, Esq. Approximatete ofmmencement of proposedle to the public:] [Our ref DLK\660390\4477549v1 Direct tel +852 2971 3005 Email jenny.nip@maplesandcalder.com Jiayuan.com International Room1005, Changxin Building No.39 Anding Road Chaoyang District Beijing The Peoples Republic of China May 9, 2011 Dear Sirs Jiayuan.com Internationalmpany Registration Statementmmission OfferingSs Shares We have actedyman Islands legalvisers to Jiayuan.com International (the] [77100.00003 May9, 2011 Jiayuan.com International Room1005, Changxin Building No.39 Anding Road Chaoyang District, Beijing The Peoples Republic of China Ladies and Gentlemen:mpany Registration Statement Securities Act Ordinary SharesSs Very truly yours, 2 OPINION OF PAUL HASTINGS REGARDING CERTAIN U.S. TAX MATTERS a2204017zex-8_2.htm 3 EX-8.2] [LEGAL OPINION To: JIAYUAN.COM INTERNATIONAL Room1005, Changxin Building May 7, 2011 Dear Sir/Madam: 1. Opinion We are lawyers qualified in the Peoples Republic of China (the 4. Based upon and subject to the foregoing, we are of the opinion that the statements set forth under theption Taxation in the Registration Statement insofar theynstitute statement of] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We herebynsent to the use in this Registration Statement on FormF-1/A of Jiayuan.com International of our reportted March8, 2011, except for Note 19(c), (e)and (f)which are of April20, 2011, relating to thensolidated financial statements of Jiayuan.com International which appears in the Registration Statement on Form F-1/A (No. 333-173619).] [LEGAL OPINION To: JIAYUAN.COM INTERNATIONAL Room1005, Changxin Building No.39 Anding Road, Chaoyang District Beijing 100029 the Peoples Republic of China May 7, 2011 Dear Sir/Madam: 1. Opinion We are lawyers qualified in the Peoples Republic of China (the 2. 3. Documents In so acting, we have examined the Registration Statement, the originals orpies certified or]

KNDI [Kandi Technologies] 8-K: DEAR FELLOW KANDI TECHNOLOGIES SHAREHOLDERS: Recently there was

[DEAR FELLOW KANDI TECHNOLOGIES SHAREHOLDERS: Recently there was an online story about our company, which was followed by significant volatility in our stock. The author presented the information in such a way that the clear implication was that some of the company’s revenue must have been inaccurately reported. That is not the case. Nearly all of the misinformation in the] [ITEM 8.01 OTHER EVENTS.]

CBPO [China Biologic Products] 8-K: (Original Filing)

[Company Contact FOR RELEASE ON MAY 9, 2011 AT 4:35 p.m. EDT (New York) China Biologic Products Reports First Quarter 2011 Results Tai'an, Shandong Province, PRC, May 9, 2011 – China Biologic Products, Inc. (NASDAQ: CBPO) (“China Biologic” or the “Company”), one of the leading plasma-based biopharmaceutical companies in the People’s Republic of China (“PRC”), today reported record sales and] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): May 9, 2011 (May 9, 2011) CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Tai'an City, Shandong, 271000 People's Republic of China 86-538 -620-2306 ____________________________________________________________ (Former name or former]

CBPO [China Biologic Products] 8-K: Company Contact FOR RELEASE ON MAY 9, 2011

[Company Contact FOR RELEASE ON MAY 9, 2011 AT 4:35 p.m. EDT (New York) China Biologic Products Reports First Quarter 2011 Results Tai'an, Shandong Province, PRC, May 9, 2011 – China Biologic Products, Inc. (NASDAQ: CBPO) (“China Biologic” or the “Company”), one of the leading plasma-based biopharmaceutical companies in the People’s Republic of China (“PRC”), today reported record sales and] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): May 9, 2011 (May 9, 2011) CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Tai'an City, Shandong, 271000 People's Republic of China 86-538 -620-2306 ____________________________________________________________ (Former name or former]

CBPO [China Biologic Products] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) For the quarterly period ended: March 31, 2011 For the transition period from ____________to _____________ CHINA BIOLOGIC PRODUCTS, INC. Delaware 75-2308816 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) No. 14 East Hushan Road (+86) 538-620-2306 ________________________________________________________________ (Former name, former address and former fiscal year, if changed since last report) Large accelerated] [CERTIFICATIONS I, Chao Ming Zhao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Y. Tristan Kuo, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. Chao Ming Zhao Chief Executive Officer] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. Y. Tristan Kuo Chief Financial Officer (Principal Financial Officer)]

UTSI [UTSTARCOMSRP.] 10-Q: (Original Filing)

[TABLE OFNTENTS PARTIFINANCIAL INFORMATION 3 ITEM 1CONDENSEDNSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) 3 ITEM 2MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIALNDITION AND RESULTS OF OPERATIONS 29 ITEM 3QUANTITATIVE AND QUALITATIVE DISCLOSURESOUT MARKET RISK 44 ITEM 4CONTROLS AND PROCEDURES 46 PARTIIOTHER INFORMATION 48 ITEM 1LEGAL PROCEEDINGS 48 ITEM 1ARISK FACTORS 48] [Property Leasentract Lessor: Zhejiang Letongmmunication EquipmentLtd. Lessee: UTStarcom TelecomLtd.ntract No.: Property Leasentract Lessor: Zhejiang Letongmmunication EquipmentLtd. (hereinafter referred to Party A)mpanydress: No.1576, Chunbo Road, Bingjiang District, Hangzhou, Zhejiang Province, China Legal Representative: Xiangguang SHI (Chairman of Board)ntactdress: No.1576, Chunbo Road, Bingjiang District, Hangzhou, Zhejiang Province, China] [CERTIFICATION I, Jack Lu, certify that: 1. I have reviewed this quarterly report on Form10-Q of UTStarcom,Inc.; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Edmond Cheng, certify that: 1. I have reviewed this quarterly report on Form10-Q of UTStarcom,Inc.; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [18 U.S.C. SECTION1350, SECTION906 OF THERBANES OXLEY ACT OF 2002 (i) (ii) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted: May9, 2011 EX-32.1 a11-9281_1ex32d1.htm 5 EX-32.1]

By | 2016-02-05T10:01:54+00:00 May 9th, 2011|Categories: Chinese Stocks, SEC Original, UTSI|Tags: , , , , , |0 Comments
Skip to toolbar